Human Health and Ecological Effects Risk Assessment, Imazapyr Risk
Total Page:16
File Type:pdf, Size:1020Kb
HUMAN HEALTH AND ECOLOGICAL EFFECTS RISK ASSESSMENT Imazapyr Risk Assessment Washington State Submitted to: Washington State Department of Agriculture Olympia, WA Submitted by: AMEC Geomatrix, Inc. Lynnwood, WA June 2009 Project 14858.000 TABLE OF CONTENTS Page ACRONYMS, ABBREVIATIONS, AND SYMBOLS.................................................................... v EXECUTIVE SUMMARY....................................................................................................... ES-i PROGRAM DESCRIPTION.............................................................................................. ES-i HUMAN HEALTH RISK ASSESSMENT ............................................................................ ES-ii ECOLOGICAL RISK ASSESSMENT................................................................................. ES-ii 1.0 INTRODUCTION ............................................................................................................ 1 2.0 IMAZAPYR APPLICATION IN FRESHWATER RIPARIAN AREAS............................... 5 2.1 CHEMICAL DESCRIPTION AND COMMERCIAL FORMULATIONS .................................. 6 2.2 APPLICATION METHODS ........................................................................................ 8 2.3 APPLICATION RATES ............................................................................................. 8 2.4 ENVIRONMENTAL PERSISTENCE AND MOBILITY ...................................................... 9 2.4.1 Persistence and Mobility of Imazapyr in Aquatic Environments............ 10 2.4.2 Persistence and Mobility of Imazapyr in Soil......................................... 11 2.4.3 Persistence of Imazapyr in Tissues....................................................... 11 3.0 HUMAN HEALTH RISK ASSESSMENT....................................................................... 13 3.1 OVERVIEW OF APPROACH ................................................................................... 13 3.2 HAZARD IDENTIFICATION ..................................................................................... 13 3.2.1 Overview ....................................................................................... 13 3.2.2 Mechanism of Action............................................................................. 14 3.2.3 Kinetics and Metabolism ....................................................................... 14 3.2.4 Acute Oral Toxicity ................................................................................ 15 3.2.5 Subchronic or Chronic Toxicity.............................................................. 16 3.2.6 Endocrine System Effects ..................................................................... 17 3.2.7 Immune System Effects ........................................................................ 17 3.2.8 Nervous System Effects........................................................................ 17 3.2.9 Reproductive and Teratogenic Effects .................................................. 18 3.2.10 Carcinogenicity and Mutagenicity.......................................................... 18 3.2.11 Dermal Exposure Effects....................................................................... 19 3.2.12 Inhalation Exposure Effects................................................................... 20 3.2.13 Inert Ingredients and Adjuvants............................................................. 20 3.2.14 Impurities ....................................................................................... 25 3.2.15 Metabolites ....................................................................................... 26 3.3 EXPOSURE ASSESSMENT .................................................................................... 26 3.3.1 Overview ....................................................................................... 27 3.3.2 Workers ....................................................................................... 27 3.3.3 General Public....................................................................................... 31 3.4 DOSE-RESPONSE ASSESSMENT .......................................................................... 39 3.4.1 Overview ....................................................................................... 39 3.4.2 Existing Guidelines for Chronic Exposure ............................................. 39 3.4.3 Acute RfD ....................................................................................... 40 3.5 RISK CHARACTERIZATION.................................................................................... 40 3.5.1 Overview ....................................................................................... 40 3.5.2 Workers ....................................................................................... 41 3.5.3 General Public....................................................................................... 42 AMEC Geomatrix, Inc. p:\wsda\14858-000 noxiousplant eis\3000 reports\imazapyrriskassessment\hhra&era_063009.doc i TABLE OF CONTENTS (Continued) 3.5.4 Sensitive Subgroups ............................................................................. 44 3.5.5 Synergistic Effects of Imazapyr in Combination with Other Herbicides and Adjuvants........................................................... 44 3.6 DATA GAPS AND UNCERTAINTY ........................................................................... 44 4.0 ECOLOGICAL RISK ASSESSMENT............................................................................ 47 4.1 OVERVIEW OF APPROACH ................................................................................... 47 4.2 HAZARD IDENTIFICATION ..................................................................................... 47 4.2.1 Overview ....................................................................................... 47 4.2.2 Toxicity to Terrestrial Organisms........................................................... 48 4.2.3 Aquatic Organisms................................................................................ 51 4.2.4 Adjuvant and Inert Ingredient Toxicity to Terrestrial and Aquatic Ecological Receptors......................................................... 54 4.3 EXPOSURE ASSESSMENT .................................................................................... 56 4.3.1 Overview ....................................................................................... 57 4.3.2 Terrestrial Animals ................................................................................ 58 4.3.3 Terrestrial Plants ................................................................................... 63 4.3.4 Soil Organisms...................................................................................... 67 4.3.5 Aquatic Organisms................................................................................ 67 4.4 DOSE-RESPONSE ASSESSMENT .......................................................................... 67 4.4.1 Overview ....................................................................................... 67 4.4.2 Toxicity to Terrestrial Organisms........................................................... 69 4.4.3 Aquatic Organisms................................................................................ 71 4.5 RISK CHARACTERIZATION.................................................................................... 73 4.5.1 Overview ....................................................................................... 73 4.5.2 Terrestrial Organisms............................................................................ 73 4.5.3 Aquatic Organisms................................................................................ 77 4.5.4 Federally Listed Species and State Species of Concern ...................... 78 4.6 UNCERTAINTIES AND DATA GAPS ........................................................................ 80 5.0 REFERENCES ............................................................................................................. 83 TABLES Table 1 Physical and Chemical Properties of Imazapyr and its Isopropylamine Salt Table 2 Water, Sediment, and Tissue Concentrations of Imazapyr in Missouri and Florida Treatment Ponds Table 3 Imazapyr Toxicity to Mammals Table 4 Summary of Modeled Concentrations of Imazapyr in a Pond and Stream Table 5 Oral Toxicity of Imazapyr to Birds Table 6 Toxicity of Imazapyr to Amphibians Table 7 Toxicity of Imazapyr to Terrestrial Invertebrates Table 8 Toxicity of Imazapyr to Terrestrial Plants Table 9 Toxicity of Imazapyr to Fish Table 10 Toxicity of Imazapyr to Aquatic Invertebrates AMEC Geomatrix, Inc. p:\wsda\14858-000 noxiousplant eis\3000 reports\imazapyrriskassessment\hhra&era_063009.doc ii TABLE OF CONTENTS (Continued) TABLES Table 11 Toxicity of Imazapyr to Aquatic Plants Table 12 Summary of Acetic Acid Toxicity Tests Table 13 Surfactant Toxicity Summary Table 14 Acute Toxicity of Nonylphenol to Aquatic Biota Table 15 Imazapyr Exposure Scenarios for Mammals and Birds FIGURES Figure 1 Imazapyr Human Health Risk Assessment Conceptual Model Figure 2 Imazapyr Ecological Risk Assessment Conceptual Model APPENDICES Appendix A Imazapyr Activity in Soil Appendix B Risk Assessment Worksheets Appendix C Threatened, Endangered, and Sensitive Species in Washington State AMEC Geomatrix, Inc. p:\wsda\14858-000 noxiousplant eis\3000 reports\imazapyrriskassessment\hhra&era_063009.doc iii AMEC Geomatrix, Inc. p:\wsda\14858-000 noxiousplant eis\3000 reports\imazapyrriskassessment\hhra&era_063009.doc